1. Home
  2. EVO vs PDX Comparison

EVO vs PDX Comparison

Compare EVO & PDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • PDX
  • Stock Information
  • Founded
  • EVO 1993
  • PDX 2019
  • Country
  • EVO Germany
  • PDX NY
  • Employees
  • EVO N/A
  • PDX N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • PDX Finance/Investors Services
  • Sector
  • EVO Health Care
  • PDX Finance
  • Exchange
  • EVO Nasdaq
  • PDX Nasdaq
  • Market Cap
  • EVO 1.4B
  • PDX 1.1B
  • IPO Year
  • EVO 2021
  • PDX N/A
  • Fundamental
  • Price
  • EVO $3.76
  • PDX $24.83
  • Analyst Decision
  • EVO Buy
  • PDX
  • Analyst Count
  • EVO 2
  • PDX 0
  • Target Price
  • EVO $5.90
  • PDX N/A
  • AVG Volume (30 Days)
  • EVO 159.9K
  • PDX N/A
  • Earning Date
  • EVO 08-13-2025
  • PDX 01-01-0001
  • Dividend Yield
  • EVO N/A
  • PDX 4.95%
  • EPS Growth
  • EVO N/A
  • PDX N/A
  • EPS
  • EVO N/A
  • PDX N/A
  • Revenue
  • EVO $851,944,444.00
  • PDX N/A
  • Revenue This Year
  • EVO $10.08
  • PDX N/A
  • Revenue Next Year
  • EVO $10.99
  • PDX N/A
  • P/E Ratio
  • EVO N/A
  • PDX N/A
  • Revenue Growth
  • EVO 1.50
  • PDX N/A
  • 52 Week Low
  • EVO $2.84
  • PDX $13.52
  • 52 Week High
  • EVO $5.64
  • PDX $21.05
  • Technical
  • Relative Strength Index (RSI)
  • EVO 41.37
  • PDX 72.57
  • Support Level
  • EVO $4.06
  • PDX $24.63
  • Resistance Level
  • EVO $4.44
  • PDX $25.25
  • Average True Range (ATR)
  • EVO 0.11
  • PDX 0.43
  • MACD
  • EVO -0.04
  • PDX 0.05
  • Stochastic Oscillator
  • EVO 0.00
  • PDX 82.50

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PIMCO Dynamic Income Strategy Fund is a non-diversified, limited term, closed-end management investment company registered under the Investment Company. The fund's primary investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective.

Share on Social Networks: